about
Cardiac and vascular protection: the potential of ONTARGET.Phenotypic Screening Identifies Synergistically Acting Natural Product Enhancing the Performance of Biomaterial Based Wound Healing.Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria.Phenotypic Screen Identifies a Small Molecule Modulating ERK2 and Promoting Stem Cell Proliferation.Angiotensin II does not affect endothelial tone in Type 1 diabetes-results of a double-blind placebo controlled trial.
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Treatment of diabetic nephropathy in its early stages.
@ast
Treatment of diabetic nephropathy in its early stages.
@en
type
label
Treatment of diabetic nephropathy in its early stages.
@ast
Treatment of diabetic nephropathy in its early stages.
@en
prefLabel
Treatment of diabetic nephropathy in its early stages.
@ast
Treatment of diabetic nephropathy in its early stages.
@en
P2093
P2860
P356
P1476
Treatment of diabetic nephropathy in its early stages.
@en
P2093
Giacomo Deferrari
Maura Ravera
Valeria Berruti
P2860
P304
P356
10.1002/DMRR.363
P577
2003-03-01T00:00:00Z